Hosted on MSN
GoodRx expects Pharma Direct revenue growth of at least 30% in 2026 amid shift to pharma manufacturer solutions
Wendy Barnes, President and CEO, emphasized that "the fourth quarter marked a strong finish to the year and reflected disciplined execution across our strategic priorities." She highlighted expansion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results